Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;46:719-724
Published online before print September 19, 2005, doi: 10.1161/01.HYP.0000185189.46698.15
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correction (v47,pe8)
Right arrow All Versions of this Article:
46/4/719    most recent
01.HYP.0000185189.46698.15v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, J.
Right arrow Articles by Yokota, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, J.
Right arrow Articles by Yokota, M.
Related Collections
Right arrow Congestive
Right arrow Cardiovascular Pharmacology
Right arrow Angiogenesis
Right arrow Hypertrophy
Right arrowRelated Articles

(Hypertension. 2005;46:719.)
© 2005 American Heart Association, Inc.


Original Articles

Nicorandil Promotes Myocardial Capillary and Arteriolar Growth in the Failing Heart of Dahl Salt-Sensitive Hypertensive Rats

Jinglan Xu; Kohzo Nagata; Koji Obata; Sahoko Ichihara; Hideo Izawa; Akiko Noda; Tetsuro Nagasaka; Mitsunori Iwase; Tomoki Naoe; Toyoaki Murohara; Mitsuhiro Yokota

From the Department of Cardiovascular Genome Science (J.X., K.O., M.Y.), Nagoya University School of Medicine, Japan; Department of Molecular Medicine and Clinical Science (J.X., T. Naoe), Department of Cardiology (H.I., T.M.), and Department of Clinical Pathophysiology (T. Nagasaka), Nagoya University Graduate School of Medicine, Japan; Nagoya University School of Health Sciences (K.N., A.N.), Japan; Life Science Research Center (S.I.), Mie University, Tsu, Japan; and Toyota Memorial Hospital (M.I.), Japan.

Correspondence to Mitsuhiro Yokota, MD, PhD, FAHA, FACC, Department of Cardiovascular Genome Science, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. E-mail myokota{at}med.nagoya-u.ac.jp

Long-term administration of vasodilators increases shear stress, which is thought to be important for vascular growth in the heart. Nicorandil, an activator of ATP-sensitive potassium channels with a nitrate-like action, is a potent vasodilator. We have now investigated the effects of nicorandil on vascular growth and gene expression in the failing heart of Dahl salt-sensitive (DS) hypertensive rats. DS rats fed a high-salt diet from 6 weeks of age develop concentric cardiac hypertrophy secondary to hypertension at 11 weeks, followed by heart failure at 18 weeks. DS rats on such a diet were treated with a nonantihypertensive oral dose of nicorandil (6 mg/kg per day) or vehicle from 11 to 18 weeks of age. Treatment of DS rats with nicorandil improved cardiac function and attenuated the development of heart failure. Myocardial capillary and arteriolar densities did not differ between vehicle-treated DS rats and age-matched controls. The abundance of mRNAs for endothelial NO synthase (eNOS), vascular endothelial growth factor (VEGF), the VEGF receptor Flt-1, and basic fibroblast growth factor (bFGF) in the myocardium was markedly reduced in vehicle-treated DS rats compared with controls. Treatment of DS rats with nicorandil greatly increased capillary and arteriolar densities and inhibited the downregulation of eNOS, VEGF, fms-like tyrosin kinase-1, and bFGF gene expression. This, nicorandil stimulates coronary capillary and arteriolar growth and thereby likely suppresses the development of heart failure in DS rats. Nicorandil may prove beneficial for the treatment of hypertensive heart failure as well as of ischemic heart disease.


Key Words: endothelial growth factors • fibroblast growth factor • potassium channels • heart failure


Related Articles:

Corrections
Hypertension 2006 47: e8. [Extract] [Full Text] [PDF]

Nicorandil: The Drug That Keeps on Giving
John C. Barbato
Hypertension 2005 46: 647-648. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C.-S. Kang, C.-C. Chen, C.-C. Lin, N.-C. Chang, and T.-M. Lee
Effect of ATP-sensitive potassium channel agonists on sympathetic hyperinnervation in postinfarcted rat hearts
Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1949 - H1959.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Miyachi, H. Yazawa, M. Furukawa, K. Tsuboi, M. Ohtake, T. Nishizawa, K. Hashimoto, T. Yokoi, T. Kojima, T. Murate, et al.
Exercise Training Alters Left Ventricular Geometry and Attenuates Heart Failure in Dahl Salt-Sensitive Hypertensive Rats
Hypertension, April 1, 2009; 53(4): 701 - 707.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T.-M. Lee, M.-S. Lin, and N.-C. Chang
Effect of ATP-Sensitive Potassium Channel Agonists on Ventricular Remodeling in Healed Rat Infarcts
J. Am. Coll. Cardiol., April 1, 2008; 51(13): 1309 - 1318.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Nagata, K. Obata, J. Xu, S. Ichihara, A. Noda, H. Kimata, T. Kato, H. Izawa, T. Murohara, and M. Yokota
Mineralocorticoid Receptor Antagonism Attenuates Cardiac Hypertrophy and Failure in Low-Aldosterone Hypertensive Rats
Hypertension, April 1, 2006; 47(4): 656 - 664.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. C. Barbato
Nicorandil: The Drug That Keeps on Giving
Hypertension, October 1, 2005; 46(4): 647 - 648.
[Full Text] [PDF]